海峡环保(603817) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 255,553,633.46, representing a year-on-year increase of 1.18%[3] - The net profit attributable to shareholders for the same period was CNY 40,130,275.95, reflecting a growth of 0.82% compared to the previous year[3] - Basic earnings per share for Q1 2023 were CNY 0.0891, up by 0.79% year-on-year[3] - Net profit for Q1 2023 was CNY 37,377,506.53, a decrease of 2.6% from CNY 38,384,494.09 in Q1 2022[16] - Operating profit for Q1 2023 was CNY 44,731,002.84, down 2.8% from CNY 47,074,531.51 in the same period last year[16] - Total revenue from operating activities increased to CNY 234,122,706.19 in Q1 2023, compared to CNY 190,361,964.12 in Q1 2022, representing a growth of 23.0%[18] Cash Flow - The net cash flow from operating activities increased by 16.44%, amounting to CNY 51,861,523.21[3] - Cash flow from operating activities netted CNY 51,861,523.21 in Q1 2023, up from CNY 44,540,402.21 in Q1 2022, an increase of 16.5%[18] - Cash flow from investing activities showed a net outflow of CNY 104,030,729.46 in Q1 2023, compared to a net outflow of CNY 126,548,972.42 in Q1 2022, indicating a reduction in investment losses[19] - Cash flow from financing activities generated a net inflow of CNY 75,909,637.83 in Q1 2023, slightly down from CNY 78,560,470.20 in Q1 2022[19] Assets and Liabilities - Total assets at the end of Q1 2023 reached CNY 5,860,600,805.28, a slight increase of 0.56% from the end of the previous year[4] - Total liabilities decreased to CNY 3,029,550,421.09 as of March 31, 2023, from CNY 3,036,539,888.30 at the end of 2022, a reduction of 0.23%[14] - The total equity of the company rose to CNY 2,567,570,276.46 as of March 31, 2023, from CNY 2,533,011,563.02 at the end of 2022, indicating a growth of approximately 1.4%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,995[8] - The largest shareholder, Fuzhou Water Group Co., Ltd., holds 51.61% of the shares, totaling 275,802,271 shares[8] Research and Development - Research and development expenses increased to CNY 6,694,105.18 in Q1 2023, compared to CNY 5,495,031.17 in Q1 2022, reflecting a growth of 21.8%[15] - The company has shown a commitment to increasing R&D investment, which is crucial for future product development and market expansion[15] Financial Health Monitoring - The company is actively monitoring its financial health, as indicated by the changes in cash reserves and accounts receivable[12] - The company reported a decrease in credit impairment losses to CNY -2,237,080.94 in Q1 2023 from CNY -9,401,472.91 in Q1 2022, indicating improved credit quality[16] Current Assets - Cash and cash equivalents as of March 31, 2023, were CNY 517,500,864.83, up from CNY 483,328,393.25 at the end of 2022, representing an increase of 7.5%[12] - Accounts receivable decreased to CNY 984,277,546.66 as of March 31, 2023, from CNY 1,040,827,529.15 at the end of 2022, a decline of 5.4%[12]